AUSTANCO

Austanco is a private investment fund that holds investments in real estates, games and early-stage startups with a massive transformative purpose (MTP). We are comfortable in investing early (angel/seed stage), yet we focus on scalable, capital-efficient technology startups. We believe in our founders, using our years of experience, expertise, execution excellence to accelerate their growth and launch them into global markets... ARP is a Biotechnology Company with a novel patented platform technology ‘Acteev'. Our lead product, a botanical topical has progressed to a Phase III multi-site osteo arthritis clinical trial in Australia, for the symptoms associated with osteoarthritis. A patent has been filed for in eleven global regions reflecting key markets.

Also known as: Austanco Pty Ltd.